Atul share news, announcements and annual reports
NSE: ATULBSE: 500027Chemicals & PetrochemicalsSmall Cap
Atul Limited · Formerly Atul Products · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1978 on BSE, May 1998 on NSE
Last close ₹5,028.50down ₹117.50 (2.28%)BSE ₹5,023.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹5,146.00.
30 Oct: open ₹5,146.00, high ₹5,146.00, low ₹4,995.00
52-week range of traded prices to 30 Oct 2026
₹4,995.00Low, 30 Oct 2026₹7,180.00High, 7 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,805 Cr352nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.18
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.25
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.60%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 70,84053.3% delivered
Atul disputes and clarifications
5 filed, newest first.
Jan 2026
Apr 2025
1 Apr · Legal
Aug 2022
19 Aug · Legal
Exchange has sought clarification from Atul Limited with respect to announcement dated 26-Apr-2022 informing about Appointment of Mr. Pradeep Banerjee.On the basis of aforesaid announcement, the Company is required to provide/clarify the following:Change in directors, key managerial personnel (Managing Director, Chief Executive Officer, Chief Financial Officer, Company Secretary etc.), Auditor and Compliance Officer: 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.
Jan 2015
15 Jan · Legal
Exchange has sought clarification from Atul Limited with respect to an announcement dated January 15, 2015, regarding the Company has two business segments, namely, 'Life Science Chemicals' and 'Performance and Other Chemicals'. The Life Science Chemical segment comprises several manufacturing facilities which include Dapsone manufacture facility. This is to intimate that the Dapsone manufacture facility located at Atul, Valsad, Gujarat has now been approved by the US FDA. On basis of above company is required to clarify following: 1. When the material commercial production has commenced. 2. Projected financial impact of commencement of commercial production.